1. Home
  2. CLDX vs LOB Comparison

CLDX vs LOB Comparison

Compare CLDX & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • LOB
  • Stock Information
  • Founded
  • CLDX N/A
  • LOB 2008
  • Country
  • CLDX United States
  • LOB United States
  • Employees
  • CLDX N/A
  • LOB N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LOB Major Banks
  • Sector
  • CLDX Health Care
  • LOB Finance
  • Exchange
  • CLDX Nasdaq
  • LOB Nasdaq
  • Market Cap
  • CLDX 1.9B
  • LOB 1.7B
  • IPO Year
  • CLDX 2008
  • LOB 2015
  • Fundamental
  • Price
  • CLDX $24.34
  • LOB $32.06
  • Analyst Decision
  • CLDX Buy
  • LOB Hold
  • Analyst Count
  • CLDX 10
  • LOB 3
  • Target Price
  • CLDX $43.80
  • LOB $40.00
  • AVG Volume (30 Days)
  • CLDX 866.0K
  • LOB 272.2K
  • Earning Date
  • CLDX 11-10-2025
  • LOB 10-22-2025
  • Dividend Yield
  • CLDX N/A
  • LOB 0.38%
  • EPS Growth
  • CLDX N/A
  • LOB N/A
  • EPS
  • CLDX N/A
  • LOB 1.49
  • Revenue
  • CLDX $2,599,000.00
  • LOB $434,209,000.00
  • Revenue This Year
  • CLDX N/A
  • LOB $44.86
  • Revenue Next Year
  • CLDX N/A
  • LOB $16.20
  • P/E Ratio
  • CLDX N/A
  • LOB $21.43
  • Revenue Growth
  • CLDX N/A
  • LOB 7.02
  • 52 Week Low
  • CLDX $14.40
  • LOB $22.68
  • 52 Week High
  • CLDX $29.05
  • LOB $50.16
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 44.59
  • LOB 42.51
  • Support Level
  • CLDX $22.10
  • LOB $31.90
  • Resistance Level
  • CLDX $26.85
  • LOB $33.02
  • Average True Range (ATR)
  • CLDX 1.20
  • LOB 0.99
  • MACD
  • CLDX -0.30
  • LOB 0.08
  • Stochastic Oscillator
  • CLDX 36.70
  • LOB 31.34

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

Share on Social Networks: